| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 53.9621 | 58 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.3085 | 24 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.5927 | 35 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.564 | 50 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.2866 | 24 |
| GSM780721 | Untreated after 4 days (C3_2) | 48.8271 | 44 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.2015 | 42 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 51.0748 | 52 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.2998 | 33 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.4227 | 11 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.0685 | 18 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 38.7069 | 4 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 47.5483 | 39 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.3583 | 43 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 50.8619 | 51 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 40.198 | 7 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 45.4451 | 29 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 50.4462 | 50 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 42.6587 | 16 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 48.0651 | 41 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.1497 | 49 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 40.1934 | 7 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.0989 | 45 |